Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on UiPath, Maintains $20 Price Target

Needham analyst Scott Berg reiterates UiPath (NYSE:PATH) with a Buy and maintains $20 price target.
byBenzinga Newsdesk
March 16, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Scott Berg reiterates UiPath (NYSE:PATH) with a Buy and maintains $20 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

EXCLUSIVE: Cannabis Tipping Point, Verano CEO Weighs In On HHS Rescheduling Proposal

By Joana Scopel
September 5, 3:08 PM
"This is a big moment for us," says George Archos, CEO of Verano Holdings Corp (CSE: VRNO)(OTCQX: VRNOF), in light of the recent announcement where the Department of Health and Human Services (HHS) recommended the Drug Enforcement Administration (DEA) to

CSE:VRNO